Nilambari Nilkanth Yewalkar

Title: Innovations by Nilambari Nilkanth Yewalkar

Introduction

Nilambari Nilkanth Yewalkar is a prominent inventor based in Pune, India. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative patents. With a total of two patents to her name, Yewalkar is recognized for her work in developing compounds that have potential therapeutic applications.

Latest Patents

Yewalkar's latest patents include "Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof." This invention relates to specific compounds that act as GPR120 agonists, which are crucial for treating diseases mediated by this receptor. The patent also covers pharmaceutical compositions that utilize these compounds for therapeutic purposes.

Another notable patent is "Pyridyl derivatives, their preparation and use." This invention focuses on pyridyl derivatives that inhibit key signaling pathways, including phosphatidylinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR). These derivatives are valuable for developing treatments for clinical conditions caused by the deregulation of these pathways.

Career Highlights

Yewalkar is currently associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. Her work at Piramal has allowed her to contribute to innovative research and development in drug formulation and therapeutic solutions.

Collaborations

Some of her notable coworkers include Sanjay Kumar and Vijaykumar Bhagwan Deore. Their collaboration has likely fostered a productive environment for innovation and research within the company.

Conclusion

Nilambari Nilkanth Yewalkar's contributions to the field of pharmaceuticals through her patents demonstrate her commitment to advancing medical science. Her work has the potential to impact the treatment of various diseases significantly.